| P2093 | author name string | Michael R Rickels | |
| | Cornelia Dalton-Bakes | |
| | Mark H Schutta | |
| | Insup Lee | |
| | Shannon O'Brien | |
| | Sanjian Chen | |
| | Amy J Peleckis | |
| | Nina A Ran | |
| | Huong-Lan Nguyen | |
| | Joseph R Naji | |
| P2860 | cites work | Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms | Q30463772 |
| | Frequency of severe hypoglycemia in insulin-dependent diabetes mellitus can be predicted from self-monitoring blood glucose data | Q30465875 |
| | Insulin sensitivity index in type 1 diabetes and following human islet transplantation: comparison of the minimal model to euglycemic clamp measures | Q33628076 |
| | Effects of antecedent GABAA activation with alprazolam on counterregulatory responses to hypoglycemia in healthy humans | Q33750645 |
| | Role of hepatic autoregulation in defense against hypoglycemia in humans | Q34627940 |
| | Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D Exchange clinic registry | Q34768952 |
| | Hypoglycemia in diabetes. | Q35135643 |
| | Evidence-informed clinical practice recommendations for treatment of type 1 diabetes complicated by problematic hypoglycemia | Q35630711 |
| | Consistency of quantitative scores of hypoglycemia severity and glycemic lability and comparison with continuous glucose monitoring system measures in long-standing type 1 diabetes | Q35659282 |
| | Diverse causes of hypoglycemia-associated autonomic failure in diabetes | Q35784420 |
| | Increased mortality of patients with diabetes reporting severe hypoglycemia | Q36181395 |
| | Real-time continuous glucose monitoring significantly reduces severe hypoglycemia in hypoglycemia-unaware patients with type 1 diabetes. | Q37331178 |
| | Restoration of self-awareness of hypoglycemia in adults with long-standing type 1 diabetes: hyperinsulinemic-hypoglycemic clamp substudy results from the HypoCOMPaSS trial | Q37331320 |
| | Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study | Q37437141 |
| | Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial | Q38443982 |
| | Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes | Q39016044 |
| | Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial. | Q39376348 |
| | Long-Term Improvement in Glucose Control and Counterregulation by Islet Transplantation for Type 1 Diabetes | Q39444068 |
| | Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection | Q44518159 |
| | Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation. | Q44816722 |
| | Use of the Continuous Glucose Monitoring System to guide therapy in patients with insulin-treated diabetes: a randomized controlled trial | Q45184502 |
| | Continuous glucose monitoring and type 1 diabetes. | Q46167100 |
| | Preventing hypoglycaemia: what is the appropriate glucose alert value? | Q46239049 |
| | The accuracy and efficacy of real-time continuous glucose monitoring sensor in patients with type 1 diabetes | Q46255544 |
| | JDRF randomized clinical trial to assess the efficacy of real-time continuous glucose monitoring in the management of type 1 diabetes: research design and methods | Q46337569 |
| | Continuous glucose monitoring and intensive treatment of type 1 diabetes | Q46380752 |
| | Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study | Q46420596 |
| | The role of intramyocellular lipids during hypoglycemia in patients with intensively treated type 1 diabetes | Q46585064 |
| | Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes | Q46659616 |
| | Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes | Q46991229 |
| | A psychoeducational program to restore hypoglycemia awareness: the DAFNE-HART pilot study. | Q47822016 |
| | Glucose autoregulation is the dominant component of the hormone-independent counterregulatory response to hypoglycemia in the conscious dog. | Q48135068 |
| | Recovery of hypoglycemia awareness in long-standing type 1 diabetes: a multicenter 2 × 2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose self-monitoring (HypoCOMPaS | Q50642265 |
| | Threshold-based insulin-pump interruption for reduction of hypoglycemia. | Q50888948 |
| | Improved Glycemic Control in Poorly Controlled Patients with Type 1 Diabetes Using Real-Time Continuous Glucose Monitoring | Q56093368 |
| | Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration | Q57412996 |
| | Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes | Q57420344 |
| | Sensor-augmented pump therapy lowers HbA1c in suboptimally controlled Type 1 diabetes; a randomized controlled trial | Q58886172 |
| | Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM | Q70495234 |
| | Improved counter-regulatory hormonal and symptomatic responses to hypoglycemia in patients with insulin-dependent diabetes mellitus after 3 months of less strict glycemic control | Q71233645 |
| | Mechanism of awareness of hypoglycemia. Perception of neurogenic (predominantly cholinergic) rather than neuroglycopenic symptoms | Q72616527 |
| | Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM | Q72800093 |
| | The direct effects of catecholamines on hepatic glucose production occur via alpha(1)- and beta(2)-receptors in the dog | Q74061261 |
| | Glycemic thresholds for activation of counterregulatory hormone and symptom responses in islet transplant recipients | Q79455744 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | type-1 diabetes | Q124407 |
| | hypoglycemia | Q202758 |
| | glucose monitoring | Q95987978 |
| P304 | page(s) | 105-114 | |
| P577 | publication date | 2018-01-01 | |
| P1433 | published in | The Journal of Clinical Endocrinology and Metabolism | Q3186902 |
| P1476 | title | Continuous Glucose Monitoring for Hypoglycemia Avoidance and Glucose Counterregulation in Long-Standing Type 1 Diabetes | |
| P478 | volume | 103 | |